The 2024 Cell & Gene Meeting on the Mesa will be delivered in a hybrid format with live programming available over the course of three days. Virtual registrants will have access to all content via livestream during the program dates. Additionally, all content will be made available on-demand within 24 hours of the live program time for all registrants to view.
11:00am – 6:00pm Early Badge Pick-up at the Arizona Biltmore (All Attendees)
7:00am – 9:00am Registration & Breakfast
7:45am – 8:45am Concurrent Workshops
8:00am – 6:00pm Partnering Meetings
9:00am – 6:00pm General Session, Panel Discussions, Company Presentations
6:00pm – 9:00pm Networking Bash
7:00am – 9:00am Registration & Breakfast
7:45am – 8:45am Concurrent Workshops
8:00am – 6:00pm Partnering Meetings
9:00am – 6:00pm General Session, Panel Discussions, Company Presentations
6:00pm – 7:00pm Cocktail Reception
7:00am – 9:00am Registration & Breakfast
7:45am – 8:45am Concurrent Workshops
8:00am – 12:00pm Partnering Meetings
9:00am – 12:00pm General Session, Panel Discussions, Company Presentations
12:00pm – 1:00pm Lunch
1:00pm Conference Closes
12:00am – 11:59pm Virtual Partnering Meetings
12:00am – 11:59pm Virtual Partnering Meetings
7:00am – 9:00am | REGISTRATION AND BREAKFAST
7:45am – 8:45am | CONCURRENT WORKSHOPS
WORKSHOP: MAXIMIZING FLEXIBILITY AND CONNECTIVITY: UNIFIED PLATFORM SOLUTIONS FOR MANUFACTURING, SCHEDULING, AND SUPPLY CHAIN MANAGEMENT
7:45am - 8:45am | FLW Ballroom E
Sponsored by L7 Informatics
Chair:
Marcia Blackmoore, Vice President of Customer Solutions, L7 Informatics
Speakers:
Eytan Abraham, Ph.D., Vice President, Business Head of Cell, Gene and Nucleic Acids Franchises, Resilience
Becky Cap, Senior Vice President, Biotherapies, Vitalant
Keith Evans, MES Practice Leader, L7 Informatics
Ian Gaudet, Ph.D., Vice President, Head of US Technical Operations, Galapagos
WORKSHOP: WHAT CAN BE DONE DURING PRE-CLINICAL DEVELOPMENT TO AVOID COMMERCIAL FAILURE?
7:45am - 8:45am | FLW Ballroom F
Sponsored by Ori Biotech
Chair:
Jason Foster, CEO and Executive Director, Ori Biotech
Speakers:
Julie Allickson, Ph.D., Director of Advanced Biotherapeutics, Center for Regenerative Biotherapeutics, Mayo Clinic
Kanika Chawla, Ph.D., Vice President, Process Sciences, CARGO Therapeutics
Matthew Hewitt, Ph.D., Vice President, Technical Officer Cell and Gene Therapy and Biologics, Charles River Laboratories
Andrew Snowden, Senior Director, Allogeneic and Autologous Cell Therapy Process Development, Johnson & Johnson
WORKSHOP: TURNING SCIENCE INTO SUCCESS - BUSINESS STRATEGIES FOR 2025 AND BEYOND CELL AND GENE THERAPY MANUFACTURING
7:45am - 8:45am | FLW Ballroom G
Sponsored by ScaleReady
Chair:
Josh Ludwig, Global Direction, Commercial Operations, ScaleReady
Speakers:
Boro Dropulic, Ph.D., Executive Director, Co-founder, Caring Cross
Ignacio Nunez, Chief Operating Officer, CellReady
Fred Paretti, Ph.D., Co-Founder and CEO, Multiply Labs
9:00am | GENERAL SESSION
ALLIANCE FOR REGENERATIVE MEDICINE BOARD VOTE AND WELCOME REMARKS
{FLW Ballroom E}
9:00am – 9:45am
Speakers:
Tim Hunt, CEO, Alliance for Regenerative Medicine (ARM)
Devyn Smith, Ph.D., CEO, Arbor Biotechnologies; Chairman, Alliance for Regenerative Medicine (ARM)
COMPANY PRESENTATIONS
{FLW Ballroom F}
9:00am – 9:45am
| 9:00am - 9:15am | Quell Therapeutics |
| 9:15am - 9:30am | Stemson Therapeutics |
| 9:30am - 9:45am | Papillon Therapeutics |
COMPANY PRESENTATIONS
{FLW Ballroom G}
9:00am – 9:45am
| 9:00am - 9:15am | BlueRock Therapeutics |
| 9:15am - 9:30am | Myeloid Therapeutics |
| 9:30am - 9:45am | Cellistic |
9:45am – 10:30am | CONCURRENT TRACKS
FIRESIDE CHAT: FORMER FDA COMMISSIONER SCOTT GOTTLIEB
{FLW Ballroom F}
9:45am – 10:30am
A champion for cell and gene therapies, Dr. Gottlieb played a pivotal role in adapting the agency to the first wave of cell and gene therapy products. Under his leadership, the FDA advanced new frameworks for the modern, safe, and effective oversight of gene therapies, cell-based regenerative medicines, targeted drugs, and digital health devices. As commissioner, Dr. Gottlieb predicted the FDA would approve 10-20 cell and gene therapy products per year by 2025.
Chair:
Lynelle Hoch, President, Cell Therapy Organization, Bristol-Myers Squibb
Speaker:
Scott Gottlieb, M.D., Former FDA Commissioner
COMPANY PRESENTATIONS
{FLW Ballroom F}
9:45am – 10:30am
| 9:45am - 10:00am | Deverra Therapeutics |
| 10:00am - 10:15am | Sernova |
| 10:15am - 10:30am | Holostem |
COMPANY PRESENTATIONS
{FLW Ballroom G}
9:45am – 10:30am
| 9:45am - 10:00am | University of Wisconsin Program for Advanced Cell Therapy (UW PACT) |
| 10:00am - 10:15am | Gates Institute |
| 10:15am - 10:30am | Excellos |
10:30am – 11:00am | MORNING BREAK
Sponsored by Sartorius
11:00am – 11:30am | CONCURRENT TRACKS
FEATURED SPEAKER: CATHERINE BOLLARD, M.D.
{FLW Ballroom E}
11:00am – 11:30am
Moderator:
Robert Ang, MBBS, President and CEO, Vor Bio
Speaker:
Catherine Bollard, M.D., Director of the Center for Cancer and Immunology Research, Children's National Hospital and The George Washington University
COMPANY PRESENTATIONS
{FLW Ballroom F}
11:00am – 11:30am
| 11:00am - 11:15am | Prime Medicine |
| 11:15am - 11:30am | DiscGenics |
COMPANY PRESENTATIONS
{FLW Ballroom G}
11:00am – 11:30am
| 11:00am - 11:15am | Kiji Therapeutics |
| 11:15am - 11:30am | Moffitt Cancer Center |
11:30am – 12:30pm | CONCURRENT TRACKS
THE FUTURE OF MEDICINE: APPROVED CELL AND GENE THERAPIES AND BREAKTHROUGHS ON THE HORIZON
{FLW Ballroom E}
11:30am – 12:30pm
This panel session will explore the latest advancements in cell and gene therapies, focusing on therapies that have received approval and those anticipated to gain approval. Experts will discuss the impact of these therapies on patient care, regulatory challenges, and future directions in the field.
Chair:
Anshul Mangal, President, Project Farma
Speakers:
Igor Bilinsky, Ph.D., Chief Operating Officer, IOVANCE Biotherapeutics
Tom Klima, Chief Commercial Officer, Chief Operating Officer, bluebird bio
Leslie Meltzer, Ph.D., Chief Medical Officer, Orchard Therapeutics
Kinnari Patel, Pharm.D., President and Chief Operating Officer, Rocket Pharma
Harpreet Singh, M.D., Chief Medical Officer, Precision for Medicine
SCIENCE SLAM: CONQUERING CMC CHALLENGES - ARE WE THERE YET?
{FLW Ballroom F}
11:30am – 12:30pm
Chair:
Rupa Pike, Ph.D., Senior Director and Global Head of Strategic Alliances, Catalent
Speakers:
Shishir Gadam, Ph.D., Chief Technology Officer, Cargo Therapeutics
Deborah Hursh, Ph.D., Consultant, Hursh Cell Therapy Consulting
Bruce Thompson, Ph.D., CEO, Kincell Bio
COMPANY PRESENTATIONS
{FLW Ballroom G}
11:30am – 12:30pm
| 11:30am - 11:45am | TreeFrog Therapeutics |
| 11:45am - 12:00pm | Nanite |
| 12:00pm - 12:15pm | Laverock Therapeutics |
| 12:15pm - 12:30pm | Viralgen |
12:30pm – 1:30pm | LUNCH
Sponsored by Culture Biosciences
1:30pm – 2:00pm | CONCURRENT TRACKS
FEATURED SPEAKER: NICOLE VERDUN, M.D.
{FLW Ballroom E}
1:30pm – 2:00pm
Moderator:
Bob Smith, Vice-Chair, Alliance for Regenerative Medicine (ARM)
Speaker:
Nicole Verdun, M.D., Super Office Director, CBER, FDA
COMPANY PRESENTATIONS
{FLW Ballroom F}
1:30pm – 2:00pm
| 1:30pm - 1:45pm | Ocugen |
| 1:45pm - 2:00pm | Rocket Pharmaceuticals |
COMPANY PRESENTATIONS
{FLW Ballroom G}
1:30pm – 2:00pm
| 1:30pm - 1:45pm | Satellite Bio |
| 1:45pm - 2:00pm | Ray Therapeutics |
2:00pm – 3:00pm | CONCURRENT TRACKS
OPPORTUNITIES FOR REGULATORY CONVERGENCE IN CELL AND GENE THERAPY
{FLW Ballroom E}
2:00pm – 3:00pm
Speakers:
Yoshiaki Maruyama, Ph.D., Director, Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency (PMDA)
Nicole Verdun, M.D., Super Office Director, CBER, FDA
COMPANY PRESENTATIONS
{FLW Ballroom F}
2:00pm – 3:00pm
| 2:00pm - 2:15pm | REGENEXBIO |
| 2:15pm - 2:30pm | Cabaletta Bio |
| 2:30pm - 2:45pm | Autolus |
| 2:45pm - 3:00pm | ExCellThera |
COMPANY PRESENTATIONS
{FLW Ballroom G}
2:00pm – 3:00pm
| 2:00pm - 2:15pm | CTI |
| 2:15pm - 2:30pm | Aspect Biosystems |
| 2:30pm - 2:45pm | Allarta Life Science |
| 2:45pm - 3:00pm | Code Biotherapeutics |
3:00pm – 3:45pm | CONCURRENT TRACKS
COMPANY PRESENTATIONS
{FLW Ballroom F}
3:00pm – 3:45pm
| 3:00pm - 3:15pm | Astellas Pharma |
| 3:15pm - 3:30pm | Kyverna Therapeutics |
| 3:30pm - 3:45pm | GENETHON |
COMPANY PRESENTATIONS
{FLW Ballroom G}
3:00pm – 3:45pm
| 3:00pm - 3:15pm | McKesson |
| 3:15pm - 3:30pm | STRM.BIO |
| 3:30pm - 3:45pm | Catalent Pharma Solutions |
3:45pm – 4:00pm | AFTERNOON BREAK
Sponsored by Sartorius
4:00pm – 5:00pm | CONCURRENT TRACKS
INVESTING IN CELL AND GENE THERAPY: CURRENT GLOBAL MARKET TRENDS
{FLW Ballroom E}
4:00pm – 5:00pm
Moderator:
David Lederman, Managing Director, Capital Markets, Chardan
Speakers:
Thomas Fellner, Ph.D., Vice President, Global Head of Operations, Cell and Gene Technologies, Lonza
Gloria Olivier, Ph.D., Senior Director, Business Development, Mayo Clinic Ventures
Jason Russell, Managing Director, Global Head of Biotechnology, Morgan Stanley
SCIENCE SLAM: NEUROLOGICAL DISEASES
{FLW Ballroom F}
4:00pm – 5:00pm
Chair:
Daniel Teasley, Ph.D., Head of Viral Vector and Biologic Modalities, MilliporeSigma
Speakers:
Olivier Danos, Ph.D., Chief Scientific Officer, REGENXBIO
Rachel McMinn, Ph.D., Founder and CEO, Neurogene
Xiaokui Zhang, Ph.D., Chief Scientific Officer, Aspen Neuroscience
COMPANY PRESENTATIONS
{FLW Ballroom G}
4:00pm – 5:00pm
| 4:00pm - 4:15pm | Avid Bioservices |
| 4:15pm - 4:30pm | PBS Biotech |
| 4:30pm - 4:45pm | NKILT Therapeutics |
| 4:45pm - 5:00pm | RoslinCT |
5:00pm – 6:00pm | CONCURRENT TRACKS
EXPLORING MANUFACTURING STRATEGIES: DECENTRALIZED VS. CENTRALIZED APPROACHES IN CELL AND GENE THERAPIES
{FLW Ballroom E}
5:00pm – 6:00pm
Chair:
Lee Buckler, Senior Vice President, Advanced Therapies, Blood Centers of America
Speakers:
Laura Alquist, Head of Global Manufacturing, Kite
Boro Dropulić, Ph.D., Executive Director, Caring Cross
Ian Gaudet, Ph.D., Vice President, Head of US Technical Operations, Galapagos
Matthew Hewitt, Ph.D., Vice President, Technical Officer Cell and Gene Therapy and Biologics, Charles River Laboratories
Lisa Kretzschmar, Senior Scientific Advisor, CGT, BioIVT
COMPANY PRESENTATIONS
{FLW Ballroom F}
5:00pm – 6:00pm
| 5:00pm - 5:15pm | Orca Bio |
| 5:15pm - 5:30pm | Aurion Biotech |
| 5:30pm - 5:45pm | AviadoBio |
| 5:45pm - 6:00pm | FibroBiologics |
COMPANY PRESENTATIONS
{FLW Ballroom G}
5:00pm – 6:00pm
| 5:00pm - 5:15pm | VERIGRAFT AB |
| 5:15pm - 5:30pm | Accelerated Biosciences |
| 5:30pm - 5:45pm | Nvelop Therapeutics |
| 5:45pm - 6:00pm | Artiva Biotherapeutics |
6:00pm | PROGRAM AND PARTNERING CLOSES
6:00pm – 9:00pm | NETWORKING BASH
Sponsored by Ecolab Life Sciences, Ensoma, The Money Channel NYC, SK pharmteco and UBC
7:00am – 9:00am | REGISTRATION AND BREAKFAST
Sponsored by Miromatrix
7:45am – 8:45am | CONCURRENT WORKSHOPS
WORKSHOP: ACCELERATING ACCESS TO CELL THERAPIES - STREAMLINING RESEARCH TRANSLATION AND EXPEDITED MANUFACTURING TECHNOLOGIES
7:45am - 8:45am | FLW Ballroom E
Sponsored by Thermo Fisher Scientific
Chair:
Betty Woo, Ph.D., Vice President of Cell, Gene and Advanced Therapies, Thermo Fisher Scientific
Speakers:
Celia Adelson, Executive Director, UCLA Broad Stem Cell Research Center
Saba Ghassemi, Ph.D., Research Assistant Professor of Pathology and Laboratory Medicine, University of Pennsylvania
Uma Lakshmipathy, Ph.D., Senior Director of Research and Development, Patheon
Karen Walker, Chief Technical Officer, Kyverna Therapeutics
WORKSHOP: MOVING CELL THERAPY CLOSER TO PATIENTS: DELIVERING IN THE COMMUNITY FOR THE COMMUNITY
7:45am - 8:45am | FLW Ballroom F
Sponsored by ZS
With significant opportunity outside of treatment centers, clinical evidence and approvals in earlier lines and expansion of manufacturing capacities, there is a need and desire to move cell therapies closer to patients in their own communities.
Chair:
Sankalp Sethi, Cell and Gene Therapy Practice Lead, ZS
Speakers:
Mert Aral, Chief Medical Officer, Huma
Lee Buckler, Senior Vice President, Advanced Therapies, Blood Centers of America
Bryan Campbell, Senior Vice President, Head of Global Program Leaders HOCT, Bristol-Myers Squibb
Jonathon DiTroia, Strategy and Product, Cell and Gene, McKesson
9:00am | GENERAL SESSION
UPDATE ON ARM'S GROW INTERNSHIP PROGRAM
{FLW Ballroom E}
9:00am – 9:30am
Speaker:
Rita Johnson-Greene, Chief Operating Officer, Alliance for Regenerative Medicine (ARM)
COMPANY PRESENTATIONS
{FLW Ballroom F}
9:00am – 9:30am
| 9:00am - 9:15am | Outpace Bio |
| 9:15am - 9:30am | Century Therapeutics |
COMPANY PRESENTATIONS
{FLW Ballroom G}
9:00am – 9:30am
| 9:00am - 9:15am | Evotec |
| 9:15am - 9:30am | Akadeum Life Sciences |
9:30am – 10:30am | CONCURRENT TRACKS
PLENARY SESSION: UNLOCKING THE POTENTIAL OF GENE EDITING - STREAMLINING DEVELOPMENT AND EXPANDING ACCESS FOR RARE DISEASE TREATMENT
{FLW Ballroom E}
9:30am – 10:30am
Moderator:
Jeff Walsh, CEO, Nvelop Therapeutics
Speakers:
Rachael Anatol, Ph.D., Deputy Super Office Director, OTP, FDA
Giuseppe Ciaramella, Ph.D., President, Beam Therapeutics
Keith Gottesdiener, M.D., President and CEO, Prime Medicine
Devyn Smith, Ph.D., CEO, Arbor Biotechnologies; Chairman, Alliance for Regenerative Medicine (ARM)
COMPANY PRESENTATIONS
{FLW Ballroom F}
9:30am – 10:30am
| 9:30am - 9:45am | Carisma Therapeutics Inc. |
| 9:45am - 10:00am | Capricor Therapeutics |
| 10:00am - 10:15am | Poseida Therapeutics |
| 10:15am - 10:30am | ImmPACT Bio |
COMPANY PRESENTATIONS
{FLW Ballroom G}
9:30am – 10:30am
| 9:30am - 9:45am | Metagenomi |
| 9:45am - 10:00am | TrakCel Limited |
| 10:00am - 10:15am | Affinia Therapeutics |
| 10:15am - 10:30am | Exo Biologics |
10:30am – 10:45am | MORNING BREAK
Sponsored by Sartorius
10:45am – 11:15am | CONCURRENT TRACKS
FIRESIDE CHAT: YOSHITSUGU SHITAKA, PH.D., CHIEF SCIENTIFIC OFFICER, ASTELLAS
{FLW Ballroom E}
10:45am – 11:15am
Chair:
Kristin Yarema, Ph.D., President and CEO, Poseida Therapeutics
Speaker:
Yoshitsugu Shitaka, Ph.D., Chief Scientific Officer, Astellas
COMPANY PRESENTATIONS
{FLW Ballroom F}
10:45am – 11:15am
| 10:45am - 11:00am | Cynata Therapeutics |
| 11:00am - 11:15am | Precigen |
COMPANY PRESENTATIONS
{FLW Ballroom G}
10:45am – 11:15am
| 10:45am - 11:00am | Advanced Medicine Partners |
| 11:00am - 11:15am | Avery Therapeutics |
11:15am – 12:15pm | CONCURRENT TRACKS
THE IMPORTANCE OF ETHICS IN CELL AND GENE THERAPIES
{FLW Ballroom E}
11:15am – 12:15pm
Chair:
Tim Hunt, CEO, Alliance for Regenerative Medicine (ARM)
Speakers:
Sarah Emond, President and CEO, Institute for Clinical and Economic Review (ICER)
Kevin FitzGerald, S.J., Ph.D., Chair, Department of Medical Humanities, Associate Professor, Creighton University
Miguel Forte, M.D., Ph.D., CEO, Kiji Therapeutics
Fran Gregory, Vice President, Emerging Therapies, Cardinal Health
SCIENCE SLAM: SYNTHETIC BIOLOGY
{FLW Ballroom F}
11:15am – 12:15pm
Chair:
Farzin Farzaneh, Ph.D., Chief Scientific Officer, Virocell
Speakers:
Aude Chapuis, M.D., Assistant Member, Fred Hutchinson Cancer Center
Narendra Maheshri, Ph.D., Head of Mammalian Engineering, Ginkgo Bioworks
Alec Nielson, Ph.D., Synthetic Biologist, Founder, and CEO, Asimov
COMPANY PRESENTATIONS
{FLW Ballroom G}
11:15am – 12:15pm
| 11:15am - 11:30am | Dimension Inx |
| 11:30am - 11:45am | Anocca |
| 11:45am - 12:00pm | Cellino |
| 12:00pm - 12:15pm | Notch Therapeutics |
12:15pm – 1:15pm | LUNCH
Sponsored by REGENXBIO
1:15pm – 1:45pm | CONCURRENT TRACKS
SPOTLIGHT SESSION: BRADLEY WATTS, PRIOR CAR-T PATIENT AND PATIENT ADVOCATE
{FLW Ballroom E}
1:15pm – 1:45pm
Chair:
Amy Nicole Nayar, Pharm.D., Vice President of U.S. Patient Advocacy and Government Affairs, Novartis
Speaker:
Bradley Watts, Prior CAR-T Patient and Patient Advocate, Emily Whitehead Foundation; Vice President, Conner Strong & Buckelew
COMPANY PRESENTATIONS
{FLW Ballroom G}
1:15pm – 1:45pm
| 1:15pm - 1:30pm | Umoja Biopharma |
| 1:30pm - 1:45pm | Aspen Neuroscience |
1:45pm – 2:45pm | CONCURRENT TRACKS
ELECTION 2024: WHAT IT MIGHT MEAN FOR CELL AND GENE THERAPY
{FLW Ballroom E}
1:45pm – 2:45pm
As the presidential, House, and Senate races unfold, the potential shifts in the balance of power between the White House and Congress could significantly alter healthcare policy. With the election just weeks away, seasoned political experts will provide valuable insights into the range of possible election outcomes and the resulting impact on the cell and gene therapy sector.
Moderator:
Erica Cischke, Vice President, Government Affairs, Alliance for Regenerative Medicine
Speakers:
Ed Perlmutter, Former Member of Congress (CO-07)
Thomas Reynolds, Former Member of Congress and House Leader (NY-26&27)
SCIENCE SLAM: CARDIOVASCULAR DISEASES
{FLW Ballroom F}
1:45pm – 2:45pm
Chair:
David Smith, Ph.D., Vice President of Development, BioCentriq
Speakers:
Jordan Lancaster, Ph.D., CEO, Avery Therapeutics
Kathy Ivey, Ph.D., Senior Vice President of Research, Tenaya Therapeutics
Monica Shah, M.D., Chief Medical Officer, CTI Clinical Trial and Consulting Services
COMPANY PRESENTATIONS
{FLW Ballroom G}
1:45pm – 2:45pm
| 1:45pm - 2:00pm | Cryoport Systems |
| 2:00pm - 2:15pm | bit.bio |
| 2:15pm - 2:30pm | AffyImmune Therapeutics |
| 2:30pm - 2:45pm | InVitria |
2:45pm – 3:15pm | AFTERNOON BREAK
Sponsored by Sartorius
3:15pm – 4:15pm | CONCURRENT TRACKS
THE POWER PLAYERS: HOW LARGE BIOPHARMA COMPANIES ARE SHAPING THE FUTURE OF CELL AND GENE THERAPY
{FLW Ballroom E}
3:15pm – 4:15pm
Chair:
Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult
Speakers:
Bert Bruce, U.S. President, Rare Disease, Pfizer
Nuno Fontes, Ph.D., Senior Vice President, Head of Global Biologics Development, Bayer Pharmaceuticals
Magdalene Pedersen, Vice President, Cell Therapy Strategy and Operations, Bristol Myers Squibb
Manny Simons, Ph.D., Senior Vice President, Gene Therapy, Eli Lilly; CEO and Co-Founder, Akouos
COMPANY PRESENTATIONS
{FLW Ballroom F}
3:15pm – 4:15pm
| 3:15pm - 3:30pm | Forge Biologics |
| 3:30pm - 3:45pm | MEDIPOST |
| 3:45pm - 4:00pm | Intellia Therapeutics |
| 4:00pm - 4:15pm | 4D Molecular Therapeutics |
COMPANY PRESENTATIONS
{FLW Ballroom G}
3:15pm – 4:15pm
| 3:15pm - 3:30pm | Cellares |
| 3:30pm - 3:45pm | Be Biopharma |
| 3:45pm - 4:00pm | Capsida Biotherapeutics |
| 4:00pm - 4:15pm | Invetech |
4:15pm – 5:15pm | CONCURRENT TRACKS
NEXT GENERATION CGT PROCESS DEVELOPMENT AND MANUFACTURING - IMPROVING EFFICIENCIES AND REDUCING COST OF GOODS
{FLW Ballroom E}
4:15pm – 5:15pm
Moderator:
Jennifer MacDonald, M.D., Chief Operating Officer, Advanced Regenerative Manufacturing Institute (ARMI)
Speakers:
Philippe Cronet, Ph.D., General Manager, Wacker Biotech US
Ken Harris, Chief Strategy and AI Officer, OmniaBio
Marinna Madrid, Ph.D., Co-Founder and Chief Product Officer, Cellino
Rick Modi, GCEO, Affinia Therapeutics
COMPANY PRESENTATIONS
{FLW Ballroom F}
4:15pm – 5:15pm
| 4:15pm - 4:30pm | Arbor Biotechnologies |
| 4:30pm - 4:45pm | PolTREG |
| 4:45pm - 5:00pm | S.Biomedics |
| 5:00pm - 5:15pm | SmartCella |
COMPANY PRESENTATIONS {FLW Ballroom G} 4:15pm – 5:15pm
| 4:15pm - 4:30pm | Capstan Therapeutics |
| 4:30pm - 4:45pm | Caribou Biosciences |
| 4:45pm - 5:00pm | Vesigen Therapeutics |
| 5:00pm - 5:15pm | Uniphar |
5:15pm – 6:00pm | CONCURRENT TRACKS
ADVANCING TISSUE ENGINEERING: INNOVATIONS IN REPAIR AND REGENERATION
{FLW Ballroom E}
5:15pm – 6:00pm
Speakers:
Geoff Hamilton, Co-Founder and CEO, Stemson Therapeutics
Caralynn Nowinski Collens, M.D., Co-Founder and CEO, Dimension Inx
COMPANY PRESENTATIONS {FLW Ballroom F} 5:15pm – 6:00pm
| 5:15pm - 5:30pm | Precision BioSciences |
| 5:30pm - 5:45pm | QuTEM |
| 5:45pm - 6:00pm | Atamyo Therapeutics |
COMPANY PRESENTATIONS
{FLW Ballroom G}
5:15pm – 6:00pm
| 5:15pm - 5:30pm | Immusoft Corporation |
| 5:30pm - 5:45pm | Children’s National Hospital |
| 5:45pm - 6:00pm | C3i Center Inc |
6:00pm | PROGRAM AND PARTNERING CLOSES
6:00pm – 7:00pm | COCKTAIL RECEPTION
Sponsored by Cellipont Bioservices, Precision for Medicine and Resilience
7:00am – 9:00am | REGISTRATION AND BREAKFAST
7:45am – 8:45am | CONCURRENT WORKSHOPS
WORKSHOP: ANATOMY OF A CGT LAUNCH - OPERATIONALIZING CELL AND GENE THERAPY
7:45am - 8:45am | FLW Ballroom E
Sponsored by Envision Pharma Group/Two Labs
Chair:
Kyle Felmet, Ph.D., Vice President, Specialty Commercialization, Two Labs
Speakers:
Austin Fisher, Vice President, Patient and Channel Access, Autolus
Rocio Manghani, Senior Vice President of Market Access, Gamida Cell
Michael Storey, Pharm.D., Medication Use Strategist, Nationwide Children's Hospital
WORKSHOP: EXPLORING INNOVATIVE FINANCING STRUCTURES IN TODAY'S DYNAMIC MARKET ENVIRONMENT
7:45am - 8:45am | FLW Ballroom F
Sponsored by SK pharmteco
Chair:
Audrey Greenberg, Founder and Officer, CBM, Global Head, SK Pharmteco
Speakers:
Tracy Dowling, Chief Business Officer and General Counsel, AskBio
Aaron Fisher, Director, ARCHIMED
Richard Porter, Ph.D., Chief Business and Scientific Officer R&D Operations, uniQure
9:00am – 9:30am | CONCURRENT TRACKS
FIRESIDE CHAT: JIMI OLAGHERE, SICKLE CELL PATIENT ADVOCATE
{FLW Ballroom E}
9:00am – 9:30am
Jimi Olaghere is a CasGevy recipient who has developed a keen interest in the advancements of Cell and Gene therapies, since his transformative participation in the groundbreaking clinical trial. He is passionate about the positive impact these therapies can have on patients in need and has become a staunch advocate for increased accessibility of gene therapies for SCD patients worldwide.
Moderator:
Luke Timmerman, Founder and Editor, Timmerman Report
Speaker:
Jimi Olaghere, Sickle Cell Warrior, CasGevy Recipient
COMPANY PRESENTATIONS
{FLW Ballroom F}
9:00am – 9:30am
| 9:00am - 9:15am | Persista Bio |
| 9:15am - 9:30am | Fractyl Health |
COMPANY PRESENTATIONS
{FLW Ballroom G}
9:00am – 9:30am
| 9:00am - 9:15am | ARMI | BioFabUSA |
| 9:15am - 9:30am | Agathos Biologics |
9:30am – 10:15am | CONCURRENT TRACKS
NEW MODELS FOR ULTRA-RARE INDICATIONS
{FLW Ballroom E}
9:30am – 10:15am
Moderator:
Sadik Kassim, Ph.D., Chief Scientific Officer and Chief Technology Officer, Danaher Genomic Medicines
Speakers:
Fred Chereau, Senior Vice President, Strategy and Business Development, Alexion, AstraZeneca Rare Disease
Debbie Drane, Senior Vice President Global Commercial Development, CSL Behring
Craig Martin, Founder, CEO, Orphan Therapeutics Accelerator
COMPANY PRESENTATIONS
{FLW Ballroom F}
9:30am – 10:15am
| 9:30am - 9:45am | CHO PLUS |
| 9:45am - 10:00am | Garuda Therapeutics |
| 10:00am - 10:15am | nVector |
COMPANY PRESENTATIONS
{FLW Ballroom G}
9:30am – 10:15am
| 9:30am - 9:45am | City of Hope - Center for Bioinnovation and Manufacturing |
| 9:45am - 10:00am | Tessera Therapeutics |
| 10:00am - 10:15am | Aldevron |
10:15am – 11:00am | CONCURRENT TRACKS
COMPANY PRESENTATIONS
{FLW Ballroom F}
10:15am – 11:00am
| 10:15am - 10:30am | Ascidian Therapeutics |
| 10:30am - 10:45am | Scribe Therapeutics |
| 10:45am - 11:00am | Avobis Bio |
COMPANY PRESENTATIONS
{FLW Ballroom G}
10:15am – 11:00am
| 10:15am - 10:30am | Cory Heidaran Charitable Foundation (CHCF) |
| 10:30am - 10:45am | MaxCyte |
| 10:45am - 11:00am | HC Bioscience |
11:00am – 12:00pm | CONCURRENT TRACKS
TOP FIVE REGULATORY AND CMC HIGHLIGHTS TO ADVANCE THE FIELD IN 2024
{FLW Ballroom E}
11:00am – 12:00pm
Chair:
Mike Mendicino, Ph.D., Chief Consultant and Advisor, Hybrid Concepts International
Speakers:
Anne-Virginie Eggimann, Chief Regulatory Officer, Tessera Therapeutics
Adrienne Farid, Ph.D., Chief Operations Officer and Head of Early Development, Century Therapeutics
Don Fink, Ph.D., Master Practice Expert, Regulatory, Dark Horse Consulting
Michael Paglia, Chief Technology Officer, ElevateBio BaseCamp
COMPANY PRESENTATIONS
{FLW Ballroom F}
11:00am – 12:00pm
| 11:00am - 11:15am | EG 427 |
| 11:15am - 11:30am | SkylarkBio |
| 11:30am - 11:45am | Aileron |
| 11:45am - 12:00pm | Armatus Bio |
COMPANY PRESENTATIONS
{FLW Ballroom G}
11:00am – 12:00pm
| 11:00am - 11:15am | Engage Bio |
| 11:15am - 11:30am | Advanced Therapies in Orthopaedics Foundation |
| 11:30am - 11:45am | Kriya Therapeutics Inc. |
| 11:45am - 12:00pm | Gordian Biotechnology |
12:00pm – 1:00pm | LUNCH
1:00pm | CONFERENCE CLOSES
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 120+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.
October 7-9, 2024
Arizona Biltmore
Phoenix, AZ
